Dark chocolate intake and cardiovascular diseases: a Mendelian randomization study

Juntao Yang,Jiedong Zhou,Jie Yang,Haifei Lou,Bingjie Zhao,Jufang Chi,Weiliang Tang

DOI: https://doi.org/10.1038/s41598-023-50351-6

IF: 4.6

2024-01-11

Scientific Reports

Abstract:Previous intervention studies have shown some benefits of dark chocolate for the cardiovascular system, but it has not been established whether dark chocolate intake is associated with the risk of cardiovascular diseases (CVDs). To investigate the causality between dark chocolate intake and the risk of CVDs, a Mendelian randomization (MR) study was conducted. We obtained summary-level data on dark chocolate intake and CVDs from publicly available genome-wide association studies. In this MR study, the main approach was to use a fixed-effect model with inverse variance weighted (IVW) and evaluate the robustness of the results via sensitivity analysis. We found that dark chocolate intake was significantly associated with the reduction of the risk of essential hypertension (EH) (OR = 0.73; 95% CI 0.60–0.88; p = 1.06 × 10 −3 ), as well as with the suggestive association to the reduced risk of venous thromboembolism (OR = 0.69; 95% CI 0.50–0.96; p = 2.81 × 10 −2 ). However, no association was found between dark chocolate intake and the other ten CVDs. Our study provides evidence for a causality between dark chocolate intake and a reduced risk of EH, which has important implications for the prevention of EH in the population.

multidisciplinary sciences

What problem does this paper attempt to address?

The study investigates the causal relationship between intake of dark chocolate and the risk of cardiovascular diseases (CVDs) using Mendelian randomization (MR) approach. Previous research has shown beneficial effects of dark chocolate on the cardiovascular system, but it is not clear whether it can reduce the risk of cardiovascular diseases. The study uses genetic variations as proxies for dark chocolate intake and analyzes genome data from a large number of European participants to identify genetic markers associated with dark chocolate intake and 12 cardiovascular diseases.

The study finds a significant inverse association between dark chocolate intake and the risk of primary hypertension (EH) (OR = 0.73), as well as a suggestive inverse association with the risk of venous thromboembolism (VTE) (OR = 0.69). However, no significant associations are observed for the other 10 cardiovascular diseases. The study highlights the potential beneficial effects of bioactive compounds, such as flavanols, in dark chocolate on cardiovascular health through improving vascular function and inhibiting platelet aggregation.

Nevertheless, previous small-scale randomized controlled trials have not established a causal effect of dark chocolate on the risk of cardiovascular diseases due to limitations such as sample size, potential confounding factors, and reverse causation. This MR study aims to minimize these limitations by using genetic instrumental variables, but the observed VTE association may be affected by horizontal pleiotropy, and causal inference cannot be established.

In summary, this study provides evidence for a causal relationship between dark chocolate intake and a reduced risk of primary hypertension, but the causal relationship with other cardiovascular diseases remains unclear. It offers potential public health implications for preventing hypertension but does not imply that consuming dark chocolate can prevent all cardiovascular diseases.